A Fixed-Sequence, Open-Label Study to Determine the Activity of SCH717454 as Assessed by Positron Emission Tomography in Subjects With Relapsed or Recurrent Colorectal Cancer
Phase of Trial: Phase II
Latest Information Update: 11 Feb 2016
At a glance
- Drugs Robatumumab (Primary) ; Antineoplastics
- Indications Colorectal cancer
- Focus Therapeutic Use
- Sponsors Schering-Plough
- 07 Jun 2011 Results presented at the 47th Annual Meeting of the American Society of Clinical Oncology.
- 16 Sep 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 12 Mar 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.